Drugplain

NDC 60923-556-65

ELEVIDYS

delandistrogene moxeparvovec-rokl · KIT

No Recall History

Elevidys is a gene therapy administered intravenously used to treat Duchenne muscular dystrophy in eligible patients. It works by delivering a functional copy of the dystrophin gene to help preserve muscle function and slow disease progression.

Key Facts

Brand Name
ELEVIDYS
Generic Name
delandistrogene moxeparvovec-rokl
NDC Code (Package)
60923-556-65
NDC Code (Product)
60923-556
Manufacturer
Sarepta Therapeutics, Inc.
Dosage Form
KIT
Route
INTRAVENOUS
Marketing Status
Application #
BLA125781
Marketing Start
06/22/2023

Recall History

No Recall History

View Full Drug Page

ELEVIDYS — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.